MoneyWorks4Me

A slight decline in the revenue of Rs. 578.29 millions was seen for the September 2023 quarter as against Rs. 605.26 millions during year-ago period.A slender decline of -28.24% was recorded to Rs. 74.72  millions from Rs. 104.12 millions in the corresponding previous quarter.Operating profit for the quarter ended September 2023 decreased to 106.39 millions as compared to 140.23 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 578.29 605.26 -4.46 1179.82 1211.23 -2.59 2367.14 2175.84 8.79
Other Income 22.74 11.21 102.85 42.71 14.35 197.63 57.34 34.27 67.32
PBIDT 106.39 140.23 -24.13 212.73 215.15 -1.12 398.85 284.55 40.17
Interest 2.21 0.26 750.00 3.71 0.40 827.50 4.13 2.85 44.91
PBDT 104.18 139.97 -25.57 209.02 180.16 16.02 360.13 281.70 27.84
Depreciation 4.55 2.04 123.04 8.48 3.97 113.60 12.05 15.26 -21.04
PBT 99.63 137.93 -27.77 200.54 176.19 13.82 348.08 266.44 30.64
TAX 24.91 33.81 -26.32 51.03 42.86 19.06 80.87 77.87 3.85
Deferred Tax -0.92 1.43 -164.34 -0.81 -7.36 -88.99 4.56 3.84 18.75
PAT 74.72 104.12 -28.24 149.51 133.33 12.14 267.21 188.57 41.70
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 18.40 23.17 -20.59 18.03 17.76 1.51 16.85 13.08 28.84
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..